DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d5bn2c/global_industry) has announced the addition of the "Global Industry Insight: Insulin Delivery Devices Market Development and Demand Forecast to 2020" report to their offering.
The global insulin delivery devices market, worth $9,499.1 million in 2014, is expected to grow at a CAGR of 7.0% during 2015-2020
The insulin syringes segment held the largest share of 33% in the global insulin delivery devices market; whereas, the insulin pump was the fastest growing segment in the same year. The insulin pump market is escalating with high growth rate due to several factors such as technological advancements in insulin pumps to maintain the level of insulin in the body, increasing awareness of diabetes, and increasing prevalence of diabetes. Rising awareness of diabetes have been imparting positive impact on insulin delivery devices market, as people are increasingly adopting new technology to maintain insulin level in body and experience better results from the delivery devices.
Diabetes is a chronic disease caused due to insufficient production or inappropriate use of insulin in the body. Insulin in delivered with the help of various delivery devices, such as insulin pumps, pen injectors, insulin syringe and jet injectors. The insulin syringes are most commonly used delivery systems for self-medication. However, for some people insulin syringe is not convenient option, which resulted in development of other devices for the treatment of diabetes. Insulin pens and pumps have various advantages, which help in delivering accurate dosage of insulin and maintain the normal level of insulin in body. Usage of insulin pen in administering insulin is less time-consuming compared to the usage of syringes and vials.
The key companies operating in the global insulin delivery device market include Medtronic, Inc., F. Hoffmann-La Roche, Ltd., Abbott Laboratories Inc. Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Becton Dickinson and Company, Insulet Corporation, B. Braun Melsungen AG, Animas Corporation, and Ypsomed Holdings AG.
Key Topics Covered:
1. Research Scope and Methodology
2. Executive Summary
3. Market Outlook
4. Global Market Size and Forecasts (2011 - 2020)
5. Insulin Delivery Devices Market Breakdown by Type
6. Insulin Delivery Devices Market Breakdown by Region
7. Competitive Positioning and Market Share Analysis
8. Company Profiles
- Abbott Laboratories, Inc.
- Animas Corporation
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Eli Lilly and Company
- F. Hoffmann-La Roche, Ltd.
- Insulet Corporation
- Medtronic, Inc.
- Novo Nordisk A/S
- Ypsomed Holdings AG
For more information visit http://www.researchandmarkets.com/research/d5bn2c/global_industry